Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Landrivon

Showing results (11-20 of 14) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 14 results.
Journal De Gynecologie, Obstetrique Et Biologie De La Reproduction|January 1, 1994
[Our experience and evaluation trial of obstetrical telemonitoring]J M Thoulon, G Landrivon, M Berland, et al.
Archives Des Maladies Du Coeur Et Des Vaisseaux|November 1, 1992
[Which anti-ischemic treatment can be prescribed during and after the acute phase of myocardial infarction?]F Delahaye, J L Genoud, C Colin, et al.
Transplantation|April 1, 1993
Cytomegalovirus infection--an etiological factor for rejection? A prospective study in 242 renal transplant patientsC Pouteil-Noble, R Ecochard, G Landrivon, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|January 1, 1992
Cytomegalovirus (CMV) excretion as a factor in the severity of CMV disease in kidney and simultaneous kidney and pancreas transplantationC Pouteil-Noble, R Ecochard, S Bosshard, et al.
Pageof 2

Showing results (11-20 of 14) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 14 results.
Journal De Gynecologie, Obstetrique Et Biologie De La Reproduction|January 1, 1994
[Our experience and evaluation trial of obstetrical telemonitoring]J M Thoulon, G Landrivon, M Berland, et al.
Archives Des Maladies Du Coeur Et Des Vaisseaux|November 1, 1992
[Which anti-ischemic treatment can be prescribed during and after the acute phase of myocardial infarction?]F Delahaye, J L Genoud, C Colin, et al.
Transplantation|April 1, 1993
Cytomegalovirus infection--an etiological factor for rejection? A prospective study in 242 renal transplant patientsC Pouteil-Noble, R Ecochard, G Landrivon, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|January 1, 1992
Cytomegalovirus (CMV) excretion as a factor in the severity of CMV disease in kidney and simultaneous kidney and pancreas transplantationC Pouteil-Noble, R Ecochard, S Bosshard, et al.
Pageof 2